Istanbul, August 6 (RHC) -– A number of global companies are searching for ways to enter the Cuban market and Turkish firms are also getting on the bandwagon, writes the Daily Sabah from Istambul.
Turkish Airlines is preparing to launch a new destination route to the island, while Turkish pharmaceutical companies have begun to get in touch with the Cubans.
The first move was made by the Istanbul-based Hasbiotech, as their general manager Seyfullah Dağıstanlı announced the initiation of the establishment of a pharmaceutical plant in Cuba following a partnership agreement with the Cubans.
Their Erciyes Teknopark-based company will be established in the first months of 2016. Dağıstanlı said that they are planning to produce Hepatitis C shots, stating that there will be a $10.7 million-facility built in Kayseri.
Dağıstanlı claimed that they are planning to sell their Hepatitis C shots for about $100, a significantly lower price than the current medication that costs about $35,000 for three months of treatment.
Dağıstanlı underlined that there are no producers that develop this medication yet, and the necessary technology will be supplied by the Cuban partners.
